QDIS Blog

A blog about chemistry, drug development, science, and technology

February 26, 2007

FDA approves Shire’s ADHD drug Vyvanse

by Ed Vawter @ 2:08 pm.  Filed under Health News, FDA, Pharma News

Seems they knew what they was doing when Shire purchased New River Pharmaceuticals. Now, the FDA has approved Vyvanse for treatment of Attention Deficit Hyperactivity Disorder (ADHD).

FDA approves Shire’s ADHD drug Vyvanse - Yahoo! News:

Here’s the Shire press release. This is big for them and for anyone suffering from ADHD. This drug seems to be better tolerated and longer lasting than other stimulates used to treat this disorder.

Other Resources

lisdexamfetamine dimesylate - Yahoo! Search Results
lisdexamfetamine dimesylate - Google Search
Google Blog Search: lisdexamfetamine dimesylate

Technorati Tags: ,

Email Ed Vawter



Related Posts:
  • Merck Gets Approval for Emend for Post-operative Vomiting and Nausea
  • FDA Approves Eli Lilly’s Cymbalta for Generalized Anxiety Disorder
  • FDA’s Approves pharmaceutical formulation intermediate (PFI)
  • FDA Approves Over The Counter Weight Loss Pills
  • Implantable Drugs

    • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    February 2007
    S M T W T F S
    « Jan   Mar »
     123
    45678910
    11121314151617
    18192021222324
    25262728  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 1.347 seconds